Breast Cancer 2, Early Onset (BRCA2) Peptid
BRCA2
Reaktivität: Human, Affe, Ratte
Wirt: Synthetic
BP
-
- Target Alle BRCA2 Produkte
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
- Spezies
- Human, Affe, Ratte
- Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP)
- Produktmerkmale
- The peptide is used to block Anti-BRCA2 Antibody reactivity.
-
- Applikationshinweise
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Lagerung
- -20 °C
- Informationen zur Lagerung
- Shipped at 4°C. Store at -20°C for one year.
- Haltbarkeit
- 12 months
-
- Target
- BRCA2 (Breast Cancer 2, Early Onset (BRCA2))
- Synonyme
- BRCC2 Peptide, BROVCA2 Peptide, FACD Peptide, FAD Peptide, FAD1 Peptide, FANCB Peptide, FANCD Peptide, FANCD1 Peptide, GLM3 Peptide, PNCA2 Peptide, 30169 Peptide, BcDNA:SD25109 Peptide, CG13583 Peptide, CG13584 Peptide, CG30169 Peptide, Dmel\\CG30169 Peptide, brca2 Peptide, dmbrca2 Peptide, fancd1 Peptide, BRCA2 Peptide, brcc2 Peptide, brovca2 Peptide, facd Peptide, fad Peptide, fad1 Peptide, fancb Peptide, AI256696 Peptide, AW045498 Peptide, Fancd1 Peptide, RAB163 Peptide, BRCA2, DNA repair associated Peptide, Breast cancer 2, early onset homolog Peptide, breast cancer 2, early onset Peptide, BRCA2 Peptide, Brca2 Peptide, brca2 Peptide, LOC584780 Peptide
- Hintergrund
- FACD, FANCD1, Breast cancer type 2 susceptibility protein, Fanconi anemia group D1 protein
- Gen-ID
- 675
- UniProt
- P51587, O35923
-
Sie sind hier:
